KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Gross Margin (2016 - 2026)

Medpace Holdings filings provide 12 years of Gross Margin readings, the most recent being 27.78% for Q1 2026.

  • On a quarterly basis, Gross Margin fell 415.0% to 27.78% in Q1 2026 year-over-year; TTM through Mar 2026 was 29.07%, a 244.0% decrease, with the full-year FY2025 number at 30.06%, down 106.0% from a year prior.
  • Gross Margin hit 27.78% in Q1 2026 for Medpace Holdings, down from 28.98% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 33.23% in Q4 2024 to a low of 26.97% in Q2 2023.
  • Median Gross Margin over the past 5 years was 29.82% (2022), compared with a mean of 29.57%.
  • Biggest five-year swings in Gross Margin: surged 578bps in 2024 and later tumbled -425bps in 2025.
  • Medpace Holdings' Gross Margin stood at 29.37% in 2022, then dropped by -7bps to 27.45% in 2023, then rose by 21bps to 33.23% in 2024, then dropped by -13bps to 28.98% in 2025, then fell by -4bps to 27.78% in 2026.
  • The last three reported values for Gross Margin were 27.78% (Q1 2026), 28.98% (Q4 2025), and 29.84% (Q3 2025) per Business Quant data.